PBS Calendars
PBS related activities surrounding the PBAC meeting cycles
- Summary of deadlines for 2026-28 PBS monthly listing and pricing process (PDF 124KB) - (Word 41KB)
- PBAC Cycle Timeframe for 2025 - 2027
- Pre-submission meetings
Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.
If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.
All contact details are available from the PBS contacts page.
PBAC Cycle Timeframe for 2026 - 2027
PBAC Cycle Timeframe for 2026 - 2027 (PDF 436KB) - (Word 64KB)
|
Meeting |
2026/1 |
2026/2 8-10 July |
2026/3 4-6 November |
2027/1 10-12 March |
2027/2 7-9 July |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Activity |
Wk |
Date |
Wk |
Date |
Wk |
Date |
Wk |
Date |
Wk |
Date |
|
Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST) |
-8 |
10 Sep 2025 |
-8 |
14 Jan 2026 |
-8 |
13 May 2026 |
-8 |
9 Sep 2026 |
-8 |
13 Jan 2027 |
|
Requested date for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST)
*NOIs will continue to be accepted up to 20 business days before the submission due day |
-8 |
17 Sept 2025 |
-8 |
14 Jan 2026 |
-8 |
13 May 2026 |
-8 |
9 Sep 2026 |
-8 |
13 Jan 2027 |
|
|
-7 |
|
-7 |
|
-7 |
|
-7 |
|
-7 |
|
|
|
-6 |
|
-6 |
|
-6 |
|
-6 |
|
-6 |
|
|
|
-5 |
|
-5 |
|
-5 |
|
-5 |
|
-5 |
|
|
Deadline for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST) |
-4 |
|
-4 |
|
-4 |
|
-4 |
|
-4 |
|
|
Deadline for integrated co-dependent submissions (Wednesday 5pm AEST) |
-4 |
8 Oct 2025 |
-4 |
11 Feb 2026 |
-4 |
10 June 2026 |
-4 |
7 Oct 2026 |
-4 |
10 Feb 2027 |
|
|
-3 |
|
-3 |
|
-3 |
|
-3 |
|
-3 |
|
|
|
-2 |
|
-2 |
|
-2 |
|
-2 |
|
-2 |
|
|
|
-1 |
|
-1 |
|
-1 |
|
-1 |
|
-1 |
|
|
Deadline for Category 1 to 4 and Committee Secretariat submissions; and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST) |
0 |
5 Nov 2025 |
0 |
11 Mar 2026 |
0 |
8 Jul 2026 |
0 |
4 Nov 2026 |
0 |
10 Mar 2027 |
|
|
1 |
|
1 |
|
1 |
|
1 |
|
1 |
|
|
Publication of the main Agenda on web (Wednesday) |
2 |
19 Nov 2025 |
2 |
25 Mar 2026 |
2 |
22 Jul 2026 |
2 |
18 Nov 2026 |
2 |
24 Mar 2027 |
|
Consumer Consultation opens (Wednesday) |
2 |
19 Nov 2025 |
2 |
25 Mar 2026 |
2 |
22 Jul 2026 |
2 |
18 Nov 2026 |
2 |
24 Mar 2027 |
|
|
3 |
|
3 |
|
3 |
|
3 |
|
3 |
|
|
|
4 |
|
4 |
|
4 |
|
4 |
|
4 |
|
|
Deadline for pre-submission meeting requests to meet 8 week cut-off |
5 |
12 Dec 2025 |
5 |
17 Apr 2026 |
5 |
14 Aug 2026 |
5 |
11 Dec 2026 |
5 |
16 Apr 2027 |
|
Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST) |
6 |
19 Dec 2025 |
6 |
24 Apr 2026 |
6 |
21 Aug 2026 |
6 |
18 Dec 2026 |
6 |
23 Apr 2027 |
|
Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST) |
7 |
2 Jan 2026 (Dept Shutdown 25 De – 1 Jan) |
7 |
1 May 2026 |
7 |
28 Aug 2026 |
7 |
24 Dec 2026 (Dept Shutdown 25 Dec – 3 Jan) |
7 |
30 Apr 2027 |
|
Publication of the updated Agenda on web (Friday) |
8 |
9 Jan 2026 |
8 |
8 May 2026 |
8 |
4 Sep 2026 |
8 |
8 Jan 2027 |
8 |
7 May 2027 |
|
Pre-submission meetings: 8 week cut-off |
9 |
12-16 Jan 2026 |
9 |
11-15 May 2026 |
9 |
7-11 Sep 2026 |
9 |
11-15 Jan 2027 |
9 |
10-14 May 2027 |
|
Consumer Consultation closes (Wednesday); |
10 |
14 Jan 2026 |
10 |
20 May 2026 |
10 |
16 Sept 2026 |
10 |
20 Jan 2027 |
10 |
19 May 2027 |
|
Submission commentaries to Applicants (Wednesday) |
10 |
21 Jan 2026 |
10 |
20 May 2026 |
10 |
16 Sep 2026 |
10 |
20 Jan 2027 |
10 |
19 May 2027 |
|
|
11 |
|
11 |
|
11 |
|
11 |
|
11 |
|
|
Applicants’ Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday) |
11 |
28 Jan 2026 |
11 |
27 May 2026 |
11 |
23 Sep 2026 |
11 |
27 Jan 2027 |
11 |
26 May 2027 |
|
DUSC and ESC meetings include joint meeting (Wednesday-Friday) |
12 |
4-6 Feb 2026 |
12 |
3-5 Jun 2026 |
12 |
30 Sep – 2 Oct |
12 |
3-5 Feb 2027 |
12 |
2-4 Jun 2027 |
|
DUSC meeting (Thursday-Friday) |
12 |
5-6 Feb 2026 |
12 |
N/A |
12 |
N/A |
12 |
N/A |
12 |
N/A |
ESC meeting (Monday-Tuesday) |
13 |
4-5 Feb 2026 |
13 |
N/A |
13 |
N/A |
13 |
N/A |
13 |
N/A |
|
Deadline for item delist submissions (Monday 5pm AEST) |
14 |
16 Feb 2026 |
14 |
15 Jun 2026 |
14 |
12 Oct 2026 |
14 |
15 Feb 2027 |
14 |
15 Jun 2027 (14 PH) |
|
Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer inputs to Applicants (Wednesday) |
15 |
25 Feb 2026 |
15 |
24 Jun 2026 |
15 |
21 Oct 2026 |
15 |
25 Feb 2027 |
15 |
23 Jun 2027 |
|
Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday) |
16 |
4 Mar 2026 |
16 |
1 Jul 2026 |
16 |
28 Oct 2026 |
16 |
3 Mar 2027 |
16 |
30 Jun 2027 |
|
PBAC MEETING (Wednesday-Friday) |
17 |
11-13 March 2026 |
17 |
8-10 July 2026 |
17 |
4-6 Nov 2026 |
17 |
10-12 March 2027 |
17 |
7-9 Jul 2027 |
|
POST PBAC PROCEDURES: |
18 |
|
18 |
|
18 |
|
18 |
|
18 |
|
|
|
19 |
|
19 |
|
19 |
|
19 |
|
19 |
|
|
Ratified Minutes (positive outcomes) to Applicants (Friday) |
20 |
2 Apr 2026 (3 Apr PH) |
20 |
31 Jul 2026 |
20 |
27 Nov 2026 |
20 |
1 Apr 2027 |
20 |
30 Jul 2027 |
|
Publication of the PBAC December Intracycle Agenda on web (Friday) |
21 |
N/A |
21 |
N/A |
21 |
4 Dec 2026 |
21 |
N/A |
21 |
N/A |
|
PBAC DECEMBER INTRACYCLE MEETING (Wednesday) |
22 |
N/A |
22 |
N/A |
22 |
9 Dec 2026 |
22 |
N/A |
22 |
N/A |
|
Ratified Minutes (all other outcomes) to Applicants (Friday) |
22 |
17 Apr 2026 |
22 |
14 Aug 2026 |
22 |
11 Dec 2026 |
22 |
16 Apr 2027 |
22 |
13 Aug 2027 |
|
Post-PBAC meetings with PBAC Chair (Tue-Wed) |
23 |
21-22 Apr 2026 |
23 |
18-19 Aug 2026 |
23 |
15-16 Dec 2026 |
23 |
20-21 Apr 2027 |
23 |
17-18 Aug 2027 |
|
Posting of outcomes on website following Applicants’ comments (Friday); and deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST) |
23 |
24 Apr 2026 |
23 |
21 Aug 2026 |
23 |
18 Dec 2026 (24 Dec – 3 Jan Dept shutdown) |
23 |
23 Apr 2027 |
23 |
20 Aug 2027 |
|
Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST) |
24 |
1 May 2026 |
24 |
28 Aug 2026 |
24 |
24 Dec 2026 (24 Dec – 3 Jan Dept shutdown) |
24 |
30 Apr 2027 |
24 |
27 Aug 2027 |
|
Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting) |
24 |
1 May 2026 |
24 |
28 Aug 2026 |
24 |
N/A |
24 |
30 Apr 2027 |
24 |
27 Aug 2027 |
|
PBAC INTRACYCLE MEETING (Friday) (except December meeting); and |
25 |
8 May 2026 |
25 |
4 Sep 2026 |
25 |
N/A |
25 |
7 May 2027 |
25 |
3 Sep 2027 |
|
PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday) |
25 |
N/A |
25 |
N/A |
25 |
8 Jan 2027 |
25 |
N/A |
25 |
N/A |
|
|
26 |
|
26 |
|
26 |
|
26 |
|
26 |
|
|
Draft Public Summary Documents (PSDs) to Applicants (Friday) |
27 |
22 May 2026 |
27 |
18 Sep 2026 |
27 |
|
27 |
21 May 2027 |
27 |
17 Sep 2027 |
|
PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday) |
27 |
|
27 |
|
27 |
22 Jan 2027 |
27 |
N/A |
27 |
N/A |
|
PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) |
28 |
N/A |
28 |
N/A |
28 |
27-28 Jan 2027 (Australia Day 26 Jan) |
28 |
N/A |
28 |
N/A |
|
PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting) |
28 |
29 May 2026 |
28 |
25 Sep 2026 |
28 |
N/A |
28 |
28 May 2027 |
28 |
24 Sep 2027 |
|
PBAC December Intracycle posting of outcomes on website (Friday) |
28 |
N/A |
28 |
N/A |
28 |
29 Jan 2027 |
28 |
N/A |
28 |
N/A |
|
|
29 |
|
29 |
|
29 |
|
29 |
|
29 |
|
|
PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday) (except December meeting) |
30 |
12 June 2026 |
30 |
9 Oct 2026 |
30 |
12 Feb 2027 |
30 |
11 June 2027 |
30 |
8 Oct 2027 |
|
PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting) |
31 |
16-17 June 2026 |
31 |
13-14 Oct 2026 |
31 |
N/A |
31 |
15-16 June 2027 |
31 |
12-13 Oct 2027 |
|
Final PSDs to Applicants (Friday); and
|
31 |
19 June 2026 |
31 |
16 Oct 2026 |
31 |
19 Feb 2027 |
31 |
18 June 2027 |
31 |
15 Oct 2027 |
|
PBAC Intracycle posting of outcomes on website (except December meeting) |
31 |
19 June 2026 |
31 |
16 Oct 2026 |
31 |
N/A |
31 |
18 June 2027 |
31 |
15 Oct 2027 |
|
Draft PBAC December Intracycle PSDs to Applicants (Friday) |
32 |
N/A |
32 |
N/A |
32 |
26 Feb 2027 |
32 |
N/A |
32 |
N/A |
|
|
33 |
|
33 |
|
33 |
|
33 |
|
33 |
|
|
|
34 |
|
34 |
|
34 |
|
34 |
|
34 |
|
|
PSDs published on website (Friday) |
35 |
17 July 2026 |
35 |
13 Nov 2026 |
35 |
19 Mar 2027 |
35 |
16 July 2027 |
35 |
12 Nov 2027 |
|
Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting) |
35 |
17 July 2026 |
35 |
13 Nov 2026 |
35 |
N/A |
35 |
16 July 2027 |
35 |
12 Nov 2027 |
|
Final PBAC December Intracycle PSDs to Applicants (Friday) |
36 |
N/A |
36 |
N/A |
36 |
25 Mar 2027 (26 Mar Good Friday) |
36 |
N/A |
36 |
N/A |
|
|
37 |
|
37 |
|
37 |
|
37 |
|
37 |
|
|
|
38 |
|
38 |
|
38 |
|
38 |
|
38 |
|
|
Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting) |
39 |
14 Aug 2026 |
39 |
11 Dec 2026 |
39 |
N/A |
39 |
13 Aug 2027 |
39 |
10 Dec 2027 |
|
PBAC December Intracycle PSDs published on website (Friday) |
40 |
N/A |
40 |
N/A |
40 |
23 Apr 2027 |
40 |
N/A |
40 |
N/A |
|
|
41 |
|
41 |
|
41 |
|
41 |
|
41 |
|
|
|
42 |
|
42 |
|
42 |
|
42 |
|
42 |
|
|
PBAC Intracycle PSDs published on website (Friday) (except December meeting) |
43 |
11 Sept 2026 |
43 |
15 Jan 2027 |
43 |
N/A |
43 |
10 Sep 2027 |
43 |
14 Jan 2028 |
ATAGI = Australian Technical Advisory Group on Immunisation
DUSC = Drug Utilisation Sub Committee
ESC = Economics Sub Committee
PBAC = Pharmaceutical Benefits Advisory Committee
PSDs = Public Summary Documents
“responsible persons” = legal wording requirement for terminology – previously known
as sponsors
TBC = To be Confirmed
* These dates may vary based on the number of submissions received
Pre-submission meetings
Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.
If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.
Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology. For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.
If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).